Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Prometheus Biosciences (RXDX) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $60.79 M
According to Prometheus Biosciences's latest financial reports the company's total liabilities are $60.79 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Prometheus Biosciences - Total liabilities on balance sheet (from 2020 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $64.8 M | 98.51% |
| 2021-12-31 | $32.64 M | -79.23% |
| 2020-12-31 | $0.15 B | 79.73% |
| 2019-12-31 | $87.45 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | $0.29 B | 378.99% | 🇺🇸 USA |
 Agenus
AGEN | $0.46 B | 657.20% | 🇺🇸 USA |